116 related articles for article (PubMed ID: 38678604)
1. Characterization of the prognostic, diagnostic, and immunological roles of DSCC1 and its genomic alteration and instability in human cancers.
Liu H; Cui Z; Wang R; Wang L; Wang L; Cheng F; Pan R; Yang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):202-211. PubMed ID: 38678604
[TBL] [Abstract][Full Text] [Related]
2. Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses.
Wang J; Gilani SF; Noor N; Ahmed MR; Munazir M; Zubair A; Sultan R; Abdel-Maksoud MA; Saleh IA; Zomot N; Kodous AS; Ibrahim SS; El-Tayeb MA; Aufy M; Zaky MY; Hassan SS; Hameed Y
Am J Transl Res; 2024; 16(3):738-754. PubMed ID: 38586115
[TBL] [Abstract][Full Text] [Related]
3. Effect of Upregulated DNA Replication and Sister Chromatid Cohesion 1 Expression on Proliferation and Prognosis in Hepatocellular Carcinoma.
Xie XW; Wang XY; Liao WJ; Fei R; Cong X; Chen Q; Wei L; Chen HS; Wang Y
Chin Med J (Engl); 2018 Dec; 131(23):2827-2835. PubMed ID: 30511685
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer.
Yamaguchi K; Yamaguchi R; Takahashi N; Ikenoue T; Fujii T; Shinozaki M; Tsurita G; Hata K; Niida A; Imoto S; Miyano S; Nakamura Y; Furukawa Y
PLoS One; 2014; 9(1):e85750. PubMed ID: 24465681
[TBL] [Abstract][Full Text] [Related]
5. DNA replication and sister chromatid cohesion 1 promotes breast carcinoma progression by modulating the Wnt/β-catenin signaling and p53 protein.
Jin G; Wang W; Cheng P; Tian Y; Zhang L; Niu HU
J Biosci; 2020; 45():. PubMed ID: 33184243
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
7. DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress.
Lin X; Liu YH; Zhang HQ; Wu LW; Li Q; Deng J; Zhang Q; Yang Y; Zhang C; Li YL; Hu J
Cancer Cell Int; 2023 Sep; 23(1):208. PubMed ID: 37742009
[TBL] [Abstract][Full Text] [Related]
8. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
10. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
Front Immunol; 2021; 12():812713. PubMed ID: 35069601
[TBL] [Abstract][Full Text] [Related]
11. DNA Replication and Sister Chromatid Cohesion 1 (DSCC1) of the Replication Factor Complex CTF18-RFC is Critical for Colon Cancer Cell Growth.
Kim JT; Cho HJ; Park SY; Oh BM; Hwang YS; Baek KE; Lee YH; Kim HC; Lee HG
J Cancer; 2019; 10(24):6142-6153. PubMed ID: 31762824
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
14. HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers.
Wu G; Dong Y; Hu Q; Ma H; Xu Q; Xu K; Chen H; Yang Z; He M
Cell Cycle; 2023 Sep; 22(18):1969-1985. PubMed ID: 37811868
[TBL] [Abstract][Full Text] [Related]
15. Roles of DSCC1 and GINS1 in gastric cancer.
Hou S; Zhang J; Chi X; Li X; Zhang Q; Kang C; Shan H
Medicine (Baltimore); 2023 Oct; 102(43):e35681. PubMed ID: 37904396
[TBL] [Abstract][Full Text] [Related]
16. MMS22L-TONSL functions in sister chromatid cohesion in a pathway parallel to DSCC1-RFC.
van Schie JJ; de Lint K; Pai GM; Rooimans MA; Wolthuis RM; de Lange J
Life Sci Alliance; 2023 Feb; 6(2):. PubMed ID: 36622344
[TBL] [Abstract][Full Text] [Related]
17. High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma.
Chang S; Zhu Y; Xi Y; Gao F; Lu J; Dong L; Ma C; Li H
Int J Gen Med; 2021; 14():6961-6974. PubMed ID: 34707388
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
19. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.
Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
Front Immunol; 2022; 13():844736. PubMed ID: 35592314
[TBL] [Abstract][Full Text] [Related]
20. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
